News and analysis on the global poultry
and animal feed industries.
Industry News & Trends
on September 14, 2016

Agrivida completes initial close in Series E funding

The company has financed over $20 million in preparation for commercialization of its patented Grainzyme feed enzyme

Agrivida Inc., an agritech company focused on animal nutrition, announces it has completed an initial close of $20.4 million Series E financing. The funds will be used to advance the commercialization of Agrivida’s patented GRAINZYME feed additive enzymes for use with poultry and swine, and to support product development for dairy and beef cattle.

The University of Texas Investment Management Company led the round and was joined by current investors ARCH Venture Partners, Cultivian Sandbox, Middleland Capital, Kleiner Perkins Caufield & Byers and Northgate Capital.

“We're excited to partner with the Agrivida team as the company prepares to commercialize its initial GRAINZYME products,” says Spencer Swayze of the University of Texas Investment Management Company that led the raise. “The company’s technology has the potential to improve the production efficiency for producers while reducing raw material and energy costs in the large and rapidly growing feed enzyme market.”

Company poised to launch breakthrough patented technologies
In addition to funding expansion of its capabilities and leadership team, the current financing will allow Agrivida to advance its regulatory and product development programs and to execute a go-to-market commercialization plan for its patented GRAINZYME Phytase technology, which uses protein expression and storage in grain to simplify the process of enzyme production. The company expects to introduce its new products in early 2017, entering the feed enzyme market, which according to Research and Markets was valued at $1.1 billion in 2015, with an annual growth rate of 7 percent.

“This is another significant milestone for our company,” says Dan Meagher, CEO of Agrivida. “Exciting results from our recent animal trials are creating a convincing value proposition for the producers of food animals. We are looking forward to delivering on our promise of improving the production efficiency of meat, milk, and eggs to help address the growing global demand for food.” 

Comments powered by Disqus